CXCR4 C1013G Mutation Molecular Detection
Desired Epic Build
* = editable field
Cerner Primary Mnemonic: | HLX CXCR4 C1013G Case |
PDM | 248466 |
Informatics - Workgroup | Molpath Inhouse |
Synonyms * | |
Display Name * | CXCR4 C1013G Mutation Molecular Detection |
Specimen Sources (combined Order Entry and Specimen Navigator) * | |
Specimen Types (combined Order Entry and Specimen Navigator) * |
Blood
|
Body Fluids (types sent through AOEs) | |
Specimen Navigator Specimen Types | |
Specimen Navigator Specimen Sources | |
Specimen Navigator Short Name | HLX CXCR4 C1013G Case |
Ordering info (EPIC SmartText) | CXCR4 C1013G Mutation Analysis CXCR4 C1013G mutation has been described as the most frequent recurrent CXCR4 mutation identified in WM patients. Most of these cases with CXCR4 mutations have concurrent MYD88 L265P mutations. This patient may be eligible for treatment with ibrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor. CXCR4 mutations are associated with resistance to ibrutinib in patients with WM. |
IP Orderable (inpatient) | Yes |
OP Orderable (outpatient) | Yes |
AOEs * | |
AP AOEs | |
Special History | No |
Build Comments | |
Filter * | |
Cerner Site Restrict | |
Cerner Results |
Actual Epic Build 3/11/2025
PROCEDURE ID | 184727 | ||||||||||||
PDM | 248466 | ||||||||||||
ORDER DISPLAY NAME | CXCR4 C1013G Mutation Analysis | ||||||||||||
PROCEDURE NAME | CXCR4 C1013G MUTATION ANALYSIS | ||||||||||||
PROCEDURE MASTER NUMBER | LAB14273 | ||||||||||||
SHORT PROCEDURE NAME | CXCR4 C1013G MUTATION ANALYSIS | ||||||||||||
CATEGORY CODE | 21.0 | ||||||||||||
CATEGORY CODE RECORD NAME | LAB MOLECULAR DIAGNOSTICS ORDERABLES | ||||||||||||
SYNONYMS | |||||||||||||
CLINICALLY ACTIVE | Yes | ||||||||||||
ORDERABLE | Yes | ||||||||||||
PERFORMABLE | Yes | ||||||||||||
FILTER GENOMICS | |||||||||||||
REFERENCE LINK URL | https://labs.northwell.edu/epic/test/184727 | ||||||||||||
ORDERING INSTRUCTIONS | |||||||||||||
DEFAULT SPECIMEN TYPE | Blood | ||||||||||||
SPECIMEN TYPE PICK LIST | Blood Bone Marrow |
||||||||||||
SPECIMEN TYPE LIST | |||||||||||||
OP SPECIMEN TYPE LIST | |||||||||||||
SPECIMEN SOURCE PICK LIST | Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous Bone Marrow |
||||||||||||
SPECIMEN SOURCE DEFAULT - MALE | Blood, Venous | ||||||||||||
SPECIMEN SOURCE DEFAULT - FEMALE | Blood, Venous | ||||||||||||
SPECIMEN SOURCE LIST | |||||||||||||
OP SPECIMEN SOURCE LIST | |||||||||||||
IP LAB TEST COMPONENTS FOR REPORT | |||||||||||||
OP LAB TEST COMPONENTS FOR REPORT | |||||||||||||
ORDER QUESTIONS | ["3048500000"] | ||||||||||||
ORDER QUESTIONS RECORD NAME | |||||||||||||
INPATIENT ORDER QUESTIONS | ["3048500000"] | ||||||||||||
INPATIENT ORDER QUESTIONS RECORD NAME | |||||||||||||
ORDER SPECIFIC QUESTION OVERRIDE | |||||||||||||
INPATIENT QUESTION OVERRIDE | |||||||||||||
LOCATION RESTRICT LIST IP | |||||||||||||
LOCATION RESTRICT LIST IP RECORD NAME | |||||||||||||
LOCATION RESTRICT LIST INCLUDE IP | |||||||||||||
LOCATION RESTRICT LIST OP | |||||||||||||
LOCATION RESTRICT LIST OP RECORD NAME | |||||||||||||
LOCATION RESTRICT LIST INCLUDES OP | |||||||||||||
EDP AMB ORDER SPECIFIC QUESTIONS RECORD NAME | NH IP PATIENT COMPLETED CONSENT | ||||||||||||
EDP IP ORDER SPECIFIC QUESTIONS RECORD NAME | NH IP PATIENT COMPLETED CONSENT | ||||||||||||
EDP IP SPECIMEN SOURCE | |||||||||||||
EDP OP SPECIMEN SOURCE | |||||||||||||
EDP IP SPECIMEN TYPE | |||||||||||||
EDP OP SPECIMEN TYPE | |||||||||||||
DERIVED EDP IP BUTTONS S | |||||||||||||
DERIVED EDP IP BUTTONS T | |||||||||||||
DERIVED EDP OP BUTTONS S | |||||||||||||
DERIVED EDP OP BUTTONS T | |||||||||||||
IP ORDERABLE | |||||||||||||
OP ORDERABLE | |||||||||||||
STANDARD LAB COMPONENTS | |||||||||||||
STANDARD LAB COMPONENTS RECORD NAME | |||||||||||||
COMPONENT DATA REQUIREMENT | |||||||||||||
EPIC OP AOEs
| |||||||||||||
EPIC IP AOEs
| |||||||||||||
EPIC Components (results - crosswalked through Cerner) |